spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Pfizer defends COVID-19 vaccine effectiveness after Trump remarks

Pfizer (PFE.N), opens new tab said on Wednesday its COVID-19 vaccine has saved more than 14 million lives worldwide, after U.S. President Donald Trump urged pharmaceutical companies to justify the success of their pandemic drugs.

In a post on Truth Social, Trump asserted that he has seen “extraordinary” data from companies such as Pfizer, but criticized them for withholding results from the public and the Centers for Disease Control and Prevention.

Pfizer welcomed Trump’s demand for openness and pointed to a dedicated section on its website where clinical trial findings and safety updates are posted.

CEO Albert Bourla praised Operation Warp Speed, the U.S. government’s 2020 initiative to accelerate vaccine development, manufacturing and distribution, calling it a “profound public health achievement” under Trump’s leadership.

He said the program helped in averting over $1 trillion in healthcare costs, adding that such an accomplishment would “typically be worthy of the Nobel Peace Prize”.

Pfizer’s announcement comes amid escalating turmoil at the CDC. Last week, director Susan Monarez was fired less than a month into her tenure after resisting changes to vaccine policy that were advanced by Health Secretary Robert F. Kennedy Jr, who was handpicked by Trump earlier this year.

Her removal sparked the resignation of four senior CDC officials, who blamed the erosion of public health credibility.

Kennedy has also rescinded federal COVID-19 vaccine recommendations for pregnant women and healthy children and halted about $500 million in funding across 22 mRNA vaccine research projects, including those targeting COVID-19.

He is set to testify before the Senate Finance Committee later this week, where lawmakers are expected to probe the CDC’s leadership crisis and ongoing policy shifts.

Pfizer also said new information on its latest vaccine strain, recently cleared by the U.S. Food and Drug Administration, will be published in the coming days

Hot this week

Bayer CEO: overhaul is leading to pharma pipeline boost

Bayer Chief Executive Bill Anderson said the company is...

Roche shares rise as company advances experimental obesity drug to late-stage trial

Shares in Roche Holding rose around 2% on Monday,...

EXPERIMENTAL ANTIBIOTIC SHOWS PROMISE AGAINST SUPERBUGS

A synthetic antibiotic is showing potent activity against some...

New US Global Health Plan Prioritizes Drugs, Recipients’ Self-Reliance

The United States will prioritize frontline health supplies, staff,...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img